HCA Healthcare Approves New Compensation Program

HCA Healthcare ( (HCA) ) just unveiled an update.

On April 24, 2025, HCA Healthcare‘s Board of Directors approved the 2025-2026 compensation program for non-management directors, which includes cash retainers and equity awards. The company also held its Annual Meeting on the same day, where key decisions were made, including the election of directors, approval of amendments to the stock incentive plan, and ratification of Ernst & Young LLP as the accounting firm. Stockholder proposals on golden parachutes and acquisition strategy were not approved.

Spark’s Take on HCA Stock

According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.

HCA Healthcare’s overall stock score reflects strong revenue growth and cash flow generation, offset by declining profit margins and high leverage. The valuation remains attractive, and the latest earnings call showcases operational resilience. However, technical indicators suggest weak momentum, which tempers the overall positive outlook.

To see Spark’s full report on HCA stock, click here.

More about HCA Healthcare

HCA Healthcare, Inc. operates in the healthcare industry, providing healthcare services through its network of hospitals and healthcare facilities. The company focuses on delivering patient care and operates a range of healthcare services, including emergency care, surgery, and specialty services.

YTD Price Performance: 10.87%

Average Trading Volume: 1,670,546

Technical Sentiment Signal: Strong Sell

Current Market Cap: $81.74B

For an in-depth examination of HCA stock, go to TipRanks’ Stock Analysis page.